SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
284.74
-0.76 (-0.27%)
Sep 17, 2025, 3:30 PM IST
SMS Pharmaceuticals Revenue
SMS Pharmaceuticals had revenue of 1.96B INR in the quarter ending June 30, 2025, with 19.21% growth. This brings the company's revenue in the last twelve months to 8.14B, up 10.29% year-over-year. In the fiscal year ending March 31, 2025, SMS Pharmaceuticals had annual revenue of 7.83B with 10.36% growth.
Revenue (ttm)
8.14B
Revenue Growth
+10.29%
P/S Ratio
3.10
Revenue / Employee
5.54M
Employees
1,197
Market Cap
25.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 7.83B | 734.85M | 10.36% |
Mar 31, 2024 | 7.09B | 1.87B | 35.86% |
Mar 31, 2023 | 5.22B | 21.77M | 0.42% |
Mar 31, 2022 | 5.20B | -433.03M | -7.69% |
Mar 31, 2021 | 5.63B | 1.49B | 35.93% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
SMS Pharmaceuticals News
- 20 days ago - SMS Pharma shares surge over 7% after USFDA grants EIR for Hyderabad facility - Business Upturn
- 2 months ago - SMS Pharmaceuticals share jump 6% after its Hyderabad facility clears USFDA inspection with zero observations - Business Upturn
- 3 months ago - SMS Pharmaceuticals clears second USFDA inspection at Hyderabad lab with zero observations - Business Upturn
- 4 months ago - SMS Pharmaceuticals’ Visakhapatnam facility receives WHO prequalification - Business Upturn
- 1 year ago - Stocks to Watch on Oct 3: Reliance Power, Ashoka Buildcon, CESC, SMS Pharma, PVR INOX, Zydus Lifesciences, Reliance Infra, and HealthCare Global in focus - Business Upturn
- 1 year ago - SMS Pharmaceuticals receives EDQM certification to supply Ibuprofen in Europe - Business Upturn